4.17
price up icon1.71%   0.07
after-market Handel nachbörslich: 4.18 0.010 +0.24%
loading
Schlusskurs vom Vortag:
$4.10
Offen:
$4
24-Stunden-Volumen:
7.65M
Relative Volume:
1.68
Marktkapitalisierung:
$835.41M
Einnahmen:
$314.00K
Nettoeinkommen (Verlust:
$-40.23M
KGV:
-14.89
EPS:
-0.28
Netto-Cashflow:
$-84.71M
1W Leistung:
+16.81%
1M Leistung:
+53.87%
6M Leistung:
+169.03%
1J Leistung:
+193.66%
1-Tages-Spanne:
Value
$3.82
$4.275
1-Wochen-Bereich:
Value
$3.06
$4.29
52-Wochen-Spanne:
Value
$1.03
$4.29

Atai Life Sciences N V Stock (ATAI) Company Profile

Name
Firmenname
Atai Life Sciences N V
Name
Telefon
49 89 2153 9035
Name
Adresse
WALLSTRASSE 16, BERLIN
Name
Mitarbeiter
54
Name
Twitter
Name
Nächster Verdiensttermin
2024-12-11
Name
Neueste SEC-Einreichungen
Name
ATAI's Discussions on Twitter

Vergleichen Sie ATAI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ATAI
Atai Life Sciences N V
4.17 869.79M 314.00K -40.23M -84.71M -0.28
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 36.65B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.46B 3.81B -644.79M -669.77M -6.24

Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-29 Eingeleitet Oppenheimer Outperform
2024-11-18 Bestätigt H.C. Wainwright Buy
2024-04-03 Hochstufung Maxim Group Hold → Buy
2022-11-01 Eingeleitet Loop Capital Buy
2021-11-30 Eingeleitet Maxim Group Buy
2021-11-11 Eingeleitet ROTH Capital Buy
2021-10-18 Eingeleitet H.C. Wainwright Buy
2021-09-01 Eingeleitet Jefferies Buy
2021-07-13 Eingeleitet Berenberg Buy
2021-07-13 Eingeleitet Canaccord Genuity Buy
2021-07-13 Eingeleitet Cantor Fitzgerald Buy
2021-07-13 Eingeleitet Citigroup Buy
2021-07-13 Eingeleitet Cowen Outperform
2021-07-13 Eingeleitet Credit Suisse Outperform
2021-07-13 Eingeleitet RBC Capital Mkts Sector Perform
2021-07-08 Eingeleitet Aegis Capital Buy
Alle ansehen

Atai Life Sciences N V Aktie (ATAI) Neueste Nachrichten

pulisher
10:19 AM

What is the risk reward ratio of investing in Atai Life Sciences N.V. stockPre Market Forecasts For Smart Trading - jammulinksnews.com

10:19 AM
pulisher
Jul 31, 2025

H.C. Wainwright Lifts PT on Atai Life Sciences (ATAI) to $15 From $10 - Insider Monkey

Jul 31, 2025
pulisher
Jul 31, 2025

AbbVie in Talks to Acquire Gilgamesh in $1 Billion Deal - Bloomberg

Jul 31, 2025
pulisher
Jul 31, 2025

H.C. Wainwright raises atai Life Sciences stock price target to $15 on BPL-003 potential - Investing.com Australia

Jul 31, 2025
pulisher
Jul 30, 2025

This IonQ Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Jul 30, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-30 03:07:04 - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

What makes Atai Life Sciences N.V. stock price move sharplySwing Setup With Technical Confirmation Explained - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

This Atai Life Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday - Benzinga

Jul 29, 2025
pulisher
Jul 29, 2025

Oppenheimer initiates atai Life Sciences stock with Outperform rating By Investing.com - Investing.com South Africa

Jul 29, 2025
pulisher
Jul 29, 2025

Oppenheimer initiates atai Life Sciences stock with Outperform rating - Investing.com

Jul 29, 2025
pulisher
Jul 29, 2025

Published on: 2025-07-29 09:29:36 - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Atai: Inidascamine Trial Failure Doesn't Matter In Main Psychedelic Pipeline Focus (ATAI) - Seeking Alpha

Jul 28, 2025
pulisher
Jul 28, 2025

ATAI Life Sciences Surges Amidst Market Uncertainty - StocksToTrade

Jul 28, 2025
pulisher
Jul 28, 2025

Why Is ATAI Life Sciences Stock Trading Lower On Monday? - Benzinga

Jul 28, 2025
pulisher
Jul 28, 2025

ATAI Life Sciences (ATAI) Stock Plunge on Trial Failure News - Yahoo Finance

Jul 28, 2025
pulisher
Jul 28, 2025

ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session - 富途牛牛

Jul 28, 2025
pulisher
Jul 28, 2025

Why Celcuity Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga

Jul 28, 2025
pulisher
Jul 28, 2025

What are analysts’ price targets for Atai Life Sciences N.V. in the next 12 monthsUnstoppable trading performance - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Nucor, Waste Management And 3 Stocks To Watch Heading Into Monday - Benzinga

Jul 28, 2025
pulisher
Jul 28, 2025

What is Atai Life Sciences N.V. company’s growth strategyGet insider insights into market trends - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

What are Atai Life Sciences N.V. company’s key revenue driversExceptional stock performance - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How volatile is Atai Life Sciences N.V. stock compared to the marketBuild wealth steadily with proven strategies - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Why Atai Life Sciences N.V. stock attracts strong analyst attentionFree Access to Community - metal.it

Jul 27, 2025
pulisher
Jul 26, 2025

Atai Life Sciences (ATAI) Shares Drop 12% After Schizophrenia Dr - GuruFocus

Jul 26, 2025
pulisher
Jul 25, 2025

Atai Life Sciences shares fall 14.29% after-hours as schizophrenia drug fails to meet main endpoint. - AInvest

Jul 25, 2025
pulisher
Jul 25, 2025

Atai Life Sciences down 12% after hours on mid-stage failure of schizophrenia asset - Seeking Alpha

Jul 25, 2025
pulisher
Jul 25, 2025

Published on: 2025-07-26 00:30:53 - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

ATAI Life Sciences stock falls after Recognify’s CIAS drug misses endpoint - Investing.com UK

Jul 25, 2025
pulisher
Jul 25, 2025

Clinical Trial Reveals Promising Signals for New Schizophrenia Cognitive Drug Despite Missed Endpoint - Stock Titan

Jul 25, 2025
pulisher
Jul 25, 2025

Canaccord Increases Atai Life Sciences (ATAI) PT, Keeps Buy Rating - Insider Monkey

Jul 25, 2025
pulisher
Jul 25, 2025

10 Best Performing Penny Stocks So Far in 2025 - Insider Monkey

Jul 25, 2025
pulisher
Jul 24, 2025

Is Atai Life Sciences N.V. a good long term investmentBreakout profit opportunities - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Canaccord Genuity Lifts Atai Life Sciences N.V. (ATAI)’s Price Target To $12, Maintains Buy Rating - MSN

Jul 24, 2025
pulisher
Jul 23, 2025

What drives Atai Life Sciences N.V. stock priceExponential return rates - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Atai Life Sciences N.V. stockMassive wealth growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

atai Life Sciences (ATAI) Upgraded to Strong Buy: Here's Why - MSN

Jul 22, 2025
pulisher
Jul 22, 2025

5-HT2 Agonist Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, Therapies, Treatment Market, Mechanism of Action, Route of Administration, and Companies by DelveInsight - The Globe and Mail

Jul 22, 2025
pulisher
Jul 19, 2025

atai Life Sciences Bets Big On Psychedelics For Mental Health - Finimize

Jul 19, 2025
pulisher
Jul 19, 2025

ATAI Impresses, CDTX Navigates With Confidence, MTSR Builds Momentum, COGT Keeps Scaling The Summit… - RTTNews

Jul 19, 2025

Finanzdaten der Atai Life Sciences N V-Aktie (ATAI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Kapitalisierung:     |  Volumen (24h):